Papers - YAMANAKA Koji
-
Blockade of Gap Junction Hemichannel Suppresses Disease Progression in Mouse Models of Amyotrophic Lateral Sclerosis and Alzheimer's Reviewed
Takeuchi H, Mizoguchi H, Doi Y, Jin S, Noda M, Liang J, Li H, Zhou Y, Mori R, Yasuoka S, Li E, Parajuli B, Kawanokuchi J, Sonobe Y, Sato J, Yamanaka K, Sobue G, Mizuno T, Suzumura A
PLoS One Vol. 6 ( 6 ) page： e21108 2011
-
Glial cells in Amyotrophic Lateral Sclerosis. Reviewed
Lasiene J, Yamanaka K
Neurol Res Int page： 718987 2011
-
A seeding reaction recapitulates intracellular formation of sarkosyl-insoluble TAR DNA binding protein-43 inclusions. Reviewed
Furukawa Y, Kaneko K, Watanabe S, Yamanaka K, Nukina N
J. Biol. Chem Vol. 286 page： 18664-18672 2011
-
Misfolded Mutant SOD1 Directly Inhibits VDAC1 Conductance in a Mouse Model of Inherited ALS. Reviewed
Israelson A, Arbel N, Da Cruz S, Ilieva H, Yamanaka K, Shoshan-Barmatz V, Clevalend DW
Neuron Vol. 67 page： 575-587 2010
-
Mutation-dependent polymorphism of Cu, Zn-superoxide dismutase aggregates in the familial form of amyotrophic lateral sclerosis. Reviewed
Furukawa Y, Kaneko K, Yamanaka K, Nukina N
J. Biol. Chem. Vol. 285 page： 22221-22231 2010
-
Schwann cells expressing dismutase active mutant SOD1 unexpectedly slow disease progression in ALS mice. Reviewed
Lobsiger CS, Boillee S, McAlonis-Downes M, Khan AM, Feltri ML, Yamanaka K, Cleveland DW
Proc. Natl. Acad. Sci., USA. Vol. 106 page： 4465-4470 2009
-
Gigaxonin controls vimentin organization through tubulin chaperone-independent pathway. Reviewed
Cleveland DW, Yamanaka K, Bomont P
Hum. Mol. Genet. Vol. 18 page： 1384-1394 2009
-
Mutant dynein (Loa) triggers proprioceptive axon loss that extends survival only in the SOD1 ALS model with highest motor neuron death. Reviewed
Ilieva H, Yamanaka K, Malkmus S, Kakinohana O, Yaksh T, Marsala M, Cleveland DW
Proc. Natl. Acad. Sci., USA. Vol. 105 page： 12599-12604 2008
-
Complete loss of post-translational modifications triggers fibrillar aggregation of SOD1 in familial form of ALS. Reviewed
Furukawa Y, Kaneko K, Yamanaka K, O'Halloran, TV, Nukina N
J. Biol. Chem. Vol. 283 page： 24167-24176 2008
-
Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Reviewed
Yamanaka K, Chun SJ, Boillee S, Fujimori-Tonou N, Yamashita H, Gutmann DH, Takahashi R, Misawa H, Cleveland DW
Nat. Neurosci. Vol. 11 page： 251-253 2008
-
Mutant SOD1 in cell types other than motor neurons and oligodendrocytes accelerates onset of disease in ALS mice. Reviewed
Yamanaka K, Boillee S, Roberts EA, Garcia ML, McAlonis-Downes M, Mikse OR, Cleveland DW, Goldstein LSB
Proc. Natl. Acad. Sci., USA. Vol. 105 page： 7594-7599 2008
-
Heat-shock protein 105 interacts with and suppresses aggregation of mutant Cu/Zn superoxide dismutase; clues to a possible strategy for treating ALS. Reviewed
Yamashita H, Kawamata J, Okawa K, Kanki R, Nakamizo T, Hatayama T, Yamanaka K, Takahashi R, Shimohama S
J. Neurochem. Vol. 102 page： 1497-1505 2007
-
Onset and Progression in Inherited ALS determined by Motor Neurons and Microglia. Reviewed
Boillee S, Yamanaka K, Lobsiger CS, Copeland NG, Jenkins NA, Kassiotis G, Kollias G, Cleveland DW
Science Vol. 312 page： 1389-1392 2006
-
Novel Missense Mutation in ALS2 gene results in Infantile Ascending Hereditary Spastic Paralysis. Reviewed
Eymard-Pierre E, Yamanaka K, Haeussler M, Kress W, Gauthier-Barichard F, Combes P, Cleveland DW, Boespflug-Tanguy O
Ann. Neurol. Vol. 59 page： 976-980 2006
-
Progressive axonal degeneration and slowness in ALS2-deficient mice. Reviewed
Yamanaka K, Miller TM, McAlonis-Downes M, Chun SJ, Cleveland DW
Ann. Neurol. Vol. 60 page： 95-104 2006
-
Antisense Oligonucleotides as a Therapy for Neurodegenerative diseases. Reviewed
Smith RA, Miller TM, Yamanaka K, Monia BP, Condon TP, Hung G, Lobsiger CS, Ward CM, McAlonis-Downes M, Wei H, Wancewicz EV, Bennett CF, Cleveland DW
J. Clin. Invest. Vol. 116 page： 2290-2296 2006
-
Gene transfer demonstrates that muscle is not a primary target for non-cell autonomous toxicity in familial amyotrophic lateral sclerosis. Reviewed
Miller TM, Kim SH, Yamanaka K, Hester M, Umapathi P, Arnson H, Rizo L, Mendell JR, Gage FH, Cleveland DW, Kaspar BK
Proc. Natl. Acad. Sci. USA Vol. 103 page： 19546-19551 2006
-
Virus-delivered siRNA preserves strength in ALS mice. Reviewed Open Access
Miller TM, Kaspar BK, Kops GJ, Yamanaka K, Christian LJ, Gage FH, Cleveland DW
Ann. Neurol. Vol. 57 page： 773-776 2005
-
Cleveland DW: Determinants of rapid disease progression in ALS. Reviewed
Yamanaka K
Neurology Vol. 65 page： 1859-1860 2005
-
ALS2-Related Disorders. Reviewed
Bertini E, Eymard-Pierre E, Boespflug-Tanguy O, Cleveland DW, Yamanaka K
GeneReviews at GeneTests: Medical Genetics Information Resource. page： 00 2005